key: cord-0778130-9w2f0h3l
authors: Lacsa, Jose Eric M
title: COVAX COVID-19 response: “we will only be safe when everybody is safe!”
date: 2021-06-17
journal: J Public Health (Oxf)
DOI: 10.1093/pubmed/fdab229
sha: 4cff56c65d11bfdfeffc320c0671e9f6a580a9f4
doc_id: 778130
cord_uid: 9w2f0h3l

nan

In a recent article published in this journal, the author addresses ASEAN centrality towards sustainable relief response to most vulnerable people in the region and therefore urges the Philippine government to build an efficient public health system and sufficient relief responses. 1 This paper adds to this discussion by citing specific 'relief responses' of an international group to the most vulnerable people in the region. COVAX is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI); Gavi, an international organization -a global Vaccine Alliance, bringing together public and private sectors with the shared goal of creating equal access to new and underused vaccines for children living in the world's poorest countries 2 ; and the World Health Organization (WHO), alongside key delivery partner United Nations Children's Fund (UNICEF). COVAX aims to accelerate the development and manufacture of COVID-19 vaccines and to guarantee fair and equitable access for every country in the world. 3 Trusting on its guiding principle: 'We will only be safe when everybody is safe,' COVAX doses had already reached at least 100 countries. To accelerate the volume of doses, COVAX hopes for the continued support of governments and manufacturers alike and would not allow complacency. 4 The Philippines for example, is one of the countries that benefited from the service given by COVAX. As the Philippines received the first 193 050 doses of donated Pfizer vaccines from the WHO-led COVAX facility, Secretary of Health Francisco Duque III gave his thanks for COVAX's help, support, and for making things possible. 5 Indeed, COVAX has given the world the best way of ensuring the fastest, most equitable rollout of safe and effective vaccines to all at-risk people in every country. The disparities that high-income countries have a higher percentage of administered coronavirus vaccine more than the lowermiddle-income countries have serious implications and limit equal access to health care, including vaccinations. It is for this purpose that the WHO is campaigning to address vaccine inequity on a global scale. 6

Strengthening ASEAN centrality on COVID-19 relief: a joint multilateral strategy policy